あすか製薬ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/01/17 | 1,931 | 1,936 | 1,913 | 1,922 | -13 | -0.7% | 59,200 |
| 2025/01/16 | 1,948 | 1,949 | 1,927 | 1,935 | -13 | -0.7% | 85,700 |
| 2025/01/15 | 1,964 | 1,972 | 1,937 | 1,948 | -20 | -1% | 62,400 |
| 2025/01/14 | 1,987 | 2,000 | 1,951 | 1,968 | -30 | -1.5% | 50,300 |
| 2025/01/10 | 2,011 | 2,015 | 1,990 | 1,998 | -20 | -1% | 39,700 |
| 2025/01/09 | 2,026 | 2,031 | 2,000 | 2,018 | +3 | +0.1% | 46,800 |
| 2025/01/08 | 2,038 | 2,049 | 2,007 | 2,015 | -23 | -1.1% | 48,100 |
| 2025/01/07 | 2,080 | 2,080 | 2,038 | 2,038 | -40 | -1.9% | 59,600 |
| 2025/01/06 | 2,105 | 2,113 | 2,078 | 2,078 | -21 | -1% | 53,200 |
| 2024/12/30 | 2,108 | 2,118 | 2,090 | 2,099 | -1 | ±0% | 47,600 |
| 2024/12/27 | 2,080 | 2,100 | 2,074 | 2,100 | +18 | +0.9% | 50,700 |
| 2024/12/26 | 2,064 | 2,082 | 2,053 | 2,082 | +23 | +1.1% | 43,200 |
| 2024/12/25 | 2,100 | 2,103 | 2,041 | 2,059 | -6 | -0.3% | 71,800 |
| 2024/12/24 | 2,066 | 2,074 | 2,059 | 2,065 | ±0 | ±0% | 39,300 |
| 2024/12/23 | 2,060 | 2,068 | 2,050 | 2,065 | +15 | +0.7% | 38,800 |
| 2024/12/20 | 2,040 | 2,060 | 2,040 | 2,050 | +14 | +0.7% | 33,000 |
| 2024/12/19 | 2,035 | 2,056 | 2,027 | 2,036 | -12 | -0.6% | 23,700 |
| 2024/12/18 | 2,048 | 2,048 | 2,037 | 2,048 | -2 | -0.1% | 20,400 |
| 2024/12/17 | 2,092 | 2,094 | 2,036 | 2,050 | -20 | -1% | 53,300 |
| 2024/12/16 | 2,080 | 2,090 | 2,065 | 2,070 | -20 | -1% | 35,400 |
| 2024/12/13 | 2,080 | 2,094 | 2,078 | 2,090 | +12 | +0.6% | 54,700 |
| 2024/12/12 | 2,087 | 2,090 | 2,072 | 2,078 | +20 | +1% | 63,200 |
| 2024/12/11 | 2,070 | 2,091 | 2,058 | 2,058 | -12 | -0.6% | 41,000 |
| 2024/12/10 | 2,059 | 2,074 | 2,051 | 2,070 | +11 | +0.5% | 61,600 |
| 2024/12/09 | 2,085 | 2,085 | 2,051 | 2,059 | +24 | +1.2% | 76,600 |
| 2024/12/06 | 2,024 | 2,043 | 1,999 | 2,035 | +48 | +2.4% | 59,300 |
| 2024/12/05 | 2,005 | 2,010 | 1,987 | 1,987 | -6 | -0.3% | 39,300 |
| 2024/12/04 | 2,025 | 2,044 | 1,986 | 1,993 | -33 | -1.6% | 61,000 |
| 2024/12/03 | 2,019 | 2,050 | 2,014 | 2,026 | +26 | +1.3% | 55,600 |
| 2024/12/02 | 1,996 | 2,010 | 1,986 | 2,000 | ±0 | ±0% | 36,000 |
| 2024/11/29 | 2,023 | 2,040 | 1,999 | 2,000 | -28 | -1.4% | 48,500 |
| 2024/11/28 | 1,995 | 2,046 | 1,995 | 2,028 | +13 | +0.6% | 58,300 |
| 2024/11/27 | 2,018 | 2,025 | 2,005 | 2,015 | -4 | -0.2% | 45,700 |
| 2024/11/26 | 2,004 | 2,019 | 1,995 | 2,019 | +8 | +0.4% | 66,900 |
| 2024/11/25 | 2,055 | 2,055 | 2,006 | 2,011 | -25 | -1.2% | 81,800 |
| 2024/11/22 | 2,031 | 2,054 | 2,028 | 2,036 | ±0 | ±0% | 28,500 |
| 2024/11/21 | 2,040 | 2,059 | 2,030 | 2,036 | -6 | -0.3% | 38,100 |
| 2024/11/20 | 2,087 | 2,087 | 2,037 | 2,042 | +5 | +0.2% | 53,500 |
| 2024/11/19 | 2,042 | 2,080 | 2,036 | 2,037 | -4 | -0.2% | 39,600 |
| 2024/11/18 | 2,032 | 2,058 | 2,013 | 2,041 | -41 | -2% | 47,600 |
| 2024/11/15 | 2,098 | 2,100 | 2,067 | 2,082 | +12 | +0.6% | 34,100 |
| 2024/11/14 | 2,097 | 2,114 | 2,070 | 2,070 | -28 | -1.3% | 46,100 |
| 2024/11/13 | 2,123 | 2,123 | 2,077 | 2,098 | -25 | -1.2% | 48,200 |
| 2024/11/12 | 2,121 | 2,154 | 2,117 | 2,123 | +2 | +0.1% | 56,900 |
| 2024/11/11 | 2,103 | 2,125 | 2,068 | 2,121 | -13 | -0.6% | 68,800 |
| 2024/11/08 | 2,162 | 2,162 | 2,133 | 2,134 | -25 | -1.2% | 105,700 |
| 2024/11/07 | 2,159 | 2,190 | 2,136 | 2,159 | +36 | +1.7% | 121,800 |
| 2024/11/06 | 2,052 | 2,123 | 1,997 | 2,123 | -64 | -2.9% | 224,600 |
| 2024/11/05 | 2,180 | 2,187 | 2,127 | 2,187 | +57 | +2.7% | 77,200 |
| 2024/11/01 | 2,135 | 2,159 | 2,122 | 2,130 | -46 | -2.1% | 56,300 |
101～
150
件表示中 / 1029件
類似銘柄と比較する
現在ご覧いただいている「あすかＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| あすかＨＤ | 233,000円 | +16.9% | +33.2% | 2.36% | 12.71倍 | 1.01倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| ネクセラファーマ | 92,000円 | +20.3% | - | 0.00% | 163.12倍 | 1.22倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ＪＣＲファーマ | 55,400円 | +14.3% | - | 3.61% | 22.50倍 | 1.44倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| タウンズ | 56,800円 | +4.6% | +6.1% | 4.93% | 9.68倍 | 3.58倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
| ヘリオス | 54,100円 | +150.0% | - | 0.00% | - | 26.61倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
市場注目の銘柄
チャート関連のコラム
